Award recordCONTRACT

ABBVIE US LLC

PIID 36C24918N1672· VHA· 626-NASHVILLE (00626)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $4,363 net obligations· UEI MAB9Y43Z1US6· IL

Description

EMERGENCY DUOPA (CARBIDOPA) 20MG.

First action · last action
2018-02-09 · 2018-06-11
Transactions
3
First transaction's obligation
$4,437
Base + all options value (sum of deltas)
$4,363
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5057B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$4,437$0Base award · 2018-02-09 · this action $4,437 · running total $4,437Modification P00001 · 2018-05-18 · this action $0 · running total $4,437Modification P00002 · 2018-06-11 · this action -$74 · running total $4,363
  • Base2018-02-09+$4,437= $4,437
  • Mod P000012018-05-18+$0= $4,437
  • Mod P000022018-06-11-$74= $4,363
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-02-09+$4,437$4,437EMERGENCY DUOPA (CARBIDOPA) 20MG.
Mod P00001· OTHER ADMINISTRATIVE ACTION2018-05-18+$0$4,437EMERGENCY DUOPA (CARBIDOPA) 20MG.
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2018-06-11−$74$4,363EMERGENCY DUOPA (CARBIDOPA) 20MG.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI MAB9Y43Z1US6)

AwardOffice · PSC / listingNet obligationsFY
36C26226P0366262-NETWORK CONTRACT OFFICE 22 (36C262) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$3,317FY2026
36C26226P0330262-NETWORK CONTRACT OFFICE 22 (36C262) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$1,432FY2026
36C26226P0199262-NETWORK CONTRACT OFFICE 22 (36C262) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$21,573FY2026
36C26026F0021260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$113,265FY2026
36C26026F0020260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$41,534FY2026
36E79725A0024NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025

Other recipients under 6505 from 626-NASHVILLE (00626) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24918N1818NEUROCRINE BIOSCIENCES, INC.626-NASHVILLE (00626)$4,660FY2018
36C24918N1434GRIFOLS THERAPEUTICS LLC626-NASHVILLE (00626)$12,807FY2018
36C24918N1339GRIFOLS THERAPEUTICS LLC626-NASHVILLE (00626)$4,489FY2018
36C24918N1321GRIFOLS THERAPEUTICS LLC626-NASHVILLE (00626)$31,050FY2018
36C24918N1265CSL BEHRING L.L.C.626-NASHVILLE (00626)$67,166FY2018

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24918N1672_3600_V797P5057B_3600 · retrieved 2026-09-26.